Post a Comment Print Share on Facebook

Permira hires Jefferies to launch Inke sale

The British venture capital fund plans to start a process to divest the generics subsidiary of its investee Neuraxpharm.

- 199 reads.

Permira hires Jefferies to launch Inke sale

The British venture capital fund plans to start a process to divest the generics subsidiary of its investee Neuraxpharm.

The British venture capital fund Permira has contracted the services of Jefferies to launch the sale process of Inke, a Spanish pharmaceutical company that is part of Neuraxpharm and whose valuation could be between 150 and 200 million euros

Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.